Oocytes accumulate an enormous quantity of mitochondrial (mt) DNA, and an insufficient amount of mtDNA may underlie some cases of poor oocyte quality leading to infertility. Little is known, however, about the mechanisms that govern the timing and regulation of mtDNA accumulation during oogenesis. We report, through analysis of the mtDNA content of individual oocytes of the mouse, that mtDNA accumulates steadily during oocyte growth to reach a value of w175 000 copies per cell. MtDNA content ceases to increase once oocytes reach full size and remains unchanged during meiotic maturation. To test whether mtDNA accumulation depends on oocyte growth, we inhibited growth in vitro in two ways -by exposing complexes comprising partially grown oocytes enclosed by granulosa cells to a chemical inhibitor of the phosphatidylinositol-3-kinase signaling pathway and by removing the surrounding granulosa cells from partially grown oocytes. Under both conditions, the oocytes fail to grow, but mtDNA accumulation is unaffected, indicating that the two processes can be mechanistically uncoupled. Quantitative analysis of the mRNAs encoding proteins required for mtDNA replication revealed that Polg (Polga) (polymerase-g, a-subunit), Polg2 (Polgb), and Tfam (transcription factor A, mitochondrial) increase during oocyte growth but then decrease after fully grown oocytes become transcriptionally silent as indicated by the non-surrounded nucleolusto-surrounded nucleolus transition. Thus, there is a correlation between the decline in the quantity of mRNAs encoding mtDNA replication factors in fully grown oocytes and the arrest of mtDNA accumulation in these cells, suggesting that the two events may be causally linked.
Introduction
Female germ cells manufacture a large stock of organelles and molecules that are inherited at fertilization by the embryo and direct its early development. Much attention has been focused on the abundance of mRNAs and the mechanisms by which these are stored and later translationally activated in a developmentally regulated manner. Equally impressive, however, is the substantial accumulation of mitochondrial (mt) DNA (Dumollard et al. 2007 , St John et al. 2010 , Van Blerkom 2010 . Although there is some variability among reports, particularly in humans, current data indicate that a mature fertilizable mammalian oocyte harbors 150 000-250 000 copies of mtDNA depending on the species (mouse (Piko & Taylor 1987 , Cao et al. 2007 , human (Steuerwald et al. 2000 , Reynier et al. 2001 , Barritt et al. 2002 , May-Panloup et al. 2005 , Santos et al. 2006 , Zeng et al. 2007 , cow (May-Panloup et al. 2007) , pig , and rat (Kameyama et al. 2007) ). As, at least in the mouse, primordial germ cells in the gonad contain about 2000 copies (Cao et al. 2007 , Wai et al. 2008 , it may be estimated that during mammalian oogenesis mtDNA content increases about 100-fold.
The accumulation of mtDNA in the oocyte serves at least two functions. First, mtDNA encodes components of the mitochondrial respiratory chain responsible for generating cellular ATP through oxidative phosphorylation, as well as tRNAs and rRNAs involved in transcription and translation of the gene products (Dumollard et al. 2007 , St John et al. 2010 , Van Blerkom 2010 . Secondly, the amount of mtDNA remains constant or declines during the cleavage stages of embryogenesis, beginning to increase only near the time of implantation when the embryo begins to grow in size (Piko & Taylor 1987 , Kameyama et al. 2007 , May-Panloup et al. 2007 , St John et al. 2010 .
This indicates that, in contrast to the oocyte, the cells of the early embryo do not replicate mtDNA. The developing oocyte must therefore produce a large quantity so that each cell of the pre-or peri-implantation embryo inherits a sufficient number of mtDNA molecules to remain viable. Decreased mitochondrial function, which could in some cases be related to defective mtDNA replication, may underlie the agerelated decline in the developmental competence of oocytes (Van Blerkom 2009 , 2010 .
In somatic cells, mtDNA replication is uncoupled from nuclear DNA replication and instead occurs throughout the cell cycle (Bogenhagen & Clayton 1977) . Several key factors are thought to drive replication (Kanki et al. 2004 , Pohjoismaki et al. 2006 , Kang et al. 2007 , Clay Montier et al. 2009 , St John et al. 2010 , Ylikallio et al. 2010 , including transcription factor associated with mitochondria (TFAM), a high-mobilitygroup; HMG-type protein that coats the mtDNA in a manner possibly analogous to the histones and nuclear DNA; DNA polymerase-g, consisting of a catalytic (POLG (POLGA)) and accessory subunit (POLG2 (POLGB)), that catalyzes synthesis of new mtDNA; nuclear respiratory factor 1 (NRF1); Twinkle, a helicase that has been proposed to be a 'licensing factor;' and mitochondrial single-stranded DNA-binding (mtSSB) protein. Although it seems likely that mtDNA replication in oocytes is similarly controlled, this has not been examined. Indeed, in contrast to the extensive studies on the 'bottleneck' mechanism that reduces mitochondrial heteroplasmy in individual oocytes (Cao et al. 2007 , Shoubridge & Wai 2007 , Cree et al. 2008 , Wai et al. 2008 , almost nothing is known about the timing and regulation of mtDNA accumulation during oocyte development. Here, we have examined mtDNA accumulation during oocyte growth in vivo and in vitro and during meiotic maturation of the mouse.
Results

Accumulation of mtDNA is correlated with oocyte growth
To define the pattern of mtDNA accumulation during oocyte growth and meiotic maturation, we took advantage of the fact that a large cohort of oocytes in mice begins to grow soon after birth and reaches full size at about 3 weeks of age. We collected oocytes from mice of different ages, measured the diameter of each, and then transferred each oocyte individually into a microtube. To enable us to correct for differences in the efficiency of DNA purification between samples, a known quantity of plasmid DNA was added to each tube. DNA was purified, and each sample was analyzed using qPCR. We found that, although the quantity of mtDNA varied among oocytes of the same size, there was a continuous increase in mtDNA copy number as oocytes grew in size, reaching a maximum of w175 000 copies (Fig. 1A) . Thus, mtDNA steadily accumulates during oocyte growth. The mathematical relationship that best fits the data shows that mtDNA content was proportional to a value less than the cube of the diameter (i.e. exponent is 1.9 rather than 3), which implies that increase in mtDNA during growth was less rapid than the increase in cellular volume.
We then tested whether mtDNA continues to accumulate after oocytes stop growing. The oocytes that begin to grow postnatally reach full size around day 18 and then stop growing. We collected oocytes from 18-and 24-day mice and then measured the diameter and mtDNA content of each oocyte as described earlier.
We detected no differences in the average size or mtDNA copy number in the oocytes collected at the two ages (Fig. 1B) . Although we cannot be certain that the oocytes collected at day 24 had completed growth by day 18, this result strongly suggests that once oocytes stop growing, accumulation of mtDNA stops as well. We then tested whether mtDNA accumulates during meiotic maturation. Fully grown oocytes were collected and the diameter was measured. Half were placed individually in microtubes and stored, while the other half were incubated for 18 h to allow meiotic maturation and then collected. mtDNA copy number was measured as earlier. We found no difference between immature and mature oocytes (Fig. 1C) . Taken together, these results indicate that mtDNA accumulates during the growth phase of oocyte development but stops when oocytes reach full size.
Accumulation of mtDNA is mechanistically uncoupled from oocyte growth
To study whether the correlation between mtDNA accumulation and oocyte growth reflected a mechanistic link, we measured the mtDNA content of oocytes grown in vitro under different conditions. Granulosa-oocyte complexes (GOCs) were isolated from preantral follicles obtained from 12-day animals. The granulosa cells were removed from half of them and the diameter of the oocyte was measured. The remaining GOCs were cultured on collagen-coated membranes for 7 days, after which the granulosa cells were removed and the oocyte diameter measured. MtDNA copy number of the oocytes was determined. The results showed that, under these culture conditions, the oocytes grew and mtDNA copy number increased by about 50% (Fig. 2A) .
We then used two strategies to test whether the increase in mtDNA copy number was dependent on oocyte growth. First, we incubated the GOCs in the presence of LY294002, a chemical inhibitor of the phosphatidylinositol-3-kinase (PI3K) signaling pathway whose activity has been implicated in oocyte growth (Zheng et al. 2012) . After 7 days of culture, the granulosa cells were removed and the diameter and mtDNA content of oocytes were determined. Because the diameter and mtDNA content of the starting population of oocytes (i.e. day 0 of culture) varied among experiments, we normalized the oocyte diameter and mtDNA in each experiment to the values recorded at the start of the culture (i.e. day 0). We found that oocytes incubated in LY294002 failed to grow, confirming the essential role of PI3K in growth (Fig. 2B ). In contrast, mtDNA accumulated to the same extent in the growthinhibited oocytes as in controls.
Next, because oocyte growth depends on physical interaction between the oocyte and its companion granulosa cells (Herlands & Schultz 1984) , we collected GOCs from 12-day mice and removed the granulosa cells from a portion. Following a 7-day culture, the diameter and mtDNA copy number of the granulosaenclosed and granulosa-free oocytes were measured as earlier. Consistent with the previous results, the granulosa-free oocytes did not grow. Nevertheless, mtDNA accumulated to the same level to that of granulosa-enclosed oocytes (Fig. 2C ). Taken together, these results indicate that mtDNA accumulation is not mechanistically coupled to oocyte growth.
Accumulation of mtDNA in growing oocytes is correlated with elevated quantities of mRNAs encoding essential replication factors As accumulation of mtDNA was not dependent on oocyte growth, we sought other factors that might account for the correlation of these two processes. As discussed in the Introduction section, mtDNA replication requires several nuclear-encoded proteins, including TFAM, NRF1, and POLG, which contains a and b subunits. Oocytes at progressively more advanced stages of growth were obtained from 12-, 15-, 18-, and 21-day Oocytes at different stages of growth were removed from the ovarian follicle, the diameter was measured, and mtDNA content was determined using qPCR. Each point represents an individual oocyte.
(B) Immature oocytes were obtained from mice of the indicated ages, the diameter was measured, and mtDNA content was determined using qPCR. (C) Immature oocytes were isolated from 20-to 22-day mice. One portion (GV) was analyzed immediately as in (B). The remainder were incubated overnight to allow meiotic maturation and those that emitted a polar body (met II) were analyzed as earlier.
For both (B) and (C), bars show mean values and S.E.M. of three independent replicates. No significant differences (NS) in mean diameter or mtDNA content were detected (t-test, P!0.05).
Accumulation of mitochondrial DNA in oocytes mice and the amount of the mRNAs encoding these proteins was quantified using qPCR. We observed that the quantity of Actb (encoding b-actin) progressively increased from 12 to 18 days and remained unchanged between 18 and 21 days (Fig. 3A) . We also observed a small increase between 12 and 15 days in the amount of Nrf1, which subsequently remained unchanged. In contrast, the quantity of Polg, Polg2, and Tfam increased from 12 to 15 days but then decreased significantly in oocytes obtained from 18 and 21-day mice. Hence, near or at the end of oocyte growth, the quantity of these mRNAs declined.
It is known that after oocytes reach full size, their transcriptional activity declines significantly and that this is correlated with a change in the conformation of the chromatin, from a relatively dispersed pattern termed non-surrounded nucleolus (NSN) to a more condensed pattern termed surrounded nucleolus (SN). To test whether the decrease in Polg, Polg2, and Tfam might be linked to transcriptional arrest, we collected oocytes from 18-day mice, anticipating that, at this age, the oocytes would be undergoing the NSN-SN transition. Oocytes were stained with Hoechst 33342, which penetrates membranes of living cells, examined using fluorescence microscopy, and separated into NSN and SN groups. We then compared the amount of the same mRNAs in these two groups. We found that Tfam and Polg were significantly decreased in the NSN oocytes compared with the SN oocytes. Thus, when oocytes reach full size and transcription stops (or decreases), the amount of mRNA encoding specific mtDNA replication factors rapidly declines.
Discussion
We report four principal findings: mtDNA accumulates steadily in growing oocytes of the mouse, mtDNA does not accumulate in fully grown or maturing oocytes, mtDNA accumulation is mechanistically uncoupled from oocyte growth, and the arrest of mtDNA accumulation in fully grown oocytes is correlated with a decrease in the quantity of mRNAs encoding mtDNA replication factors.
Previous studies have demonstrated that fully grown oocytes harbor a large amount of mtDNA, ranging in mice from about 150 000 to 175 000 copies, and our results confirm these earlier reports. However, until now, little was known about the timing or control of mtDNA accumulation in oocytes. Our results indicate that mtDNA accumulation is correlated with oocyte growth, although possibly less rapidly than the increase in cellular volume. The link between mtDNA accumulation and growth in oocytes may be compared with the pattern in somatic cells, where mtDNA replication occurs throughout the cell growth cycle (Bogenhagen & Clayton 1977) . In this context, it is intriguing to note that, following fertilization, mtDNA content remains constant until it begins to increase near the time of implantation, which corresponds to the time that the embryo begins to increase in mass. These results taken together suggest that a link exists between the signals (A) Granulosa-oocyte complexes (GOCs) were harvested from 12-day mice. The granulosa cells were removed from one portion and the diameter was measured. The remaining GOCs were incubated for 7 days, after which the oocyte diameter was measured. MtDNA content of both groups was then measured in the same qPCR. Mean and S.E.M. of five independent replicates are shown. Different letters above bars indicate a statistically significant difference (t-test, P!0.05). (B) GOCs were harvested and processed as in (A), except that GOCs were incubated in the presence of 25 mM LY294002, an inhibitor of PI3K, or the carrier, DMSO.
Results are normalized to day-0 values because the initial diameter and mtDNA content of oocytes varied among different groups of mice. Mean and S.E.M. of four independent replicates are shown. (C) As in (A), except that the granulosa cells were removed from a portion of the oocytes before they were placed in culture. Mean and S.E.M. of four independent replicates are shown. For (B) and (C), different letters above bars indicate a statistically significant difference (one-way ANOVA with Tukey's HSD test).
that stimulate cellular growth (the oocyte in this case) and mtDNA accumulation respectively. Despite the link between oocyte growth and mtDNA replication, we found using two independent methods that these could be mechanistically uncoupled. First, we used a chemical inhibitor of PI3K signaling activity, which has been implicated in both oocyte and granulosa cell development (Zheng et al. 2012) . In the oocyte, PI3K has been implicated in growth on the basis of evidence that Kit ligand, acting on Kit receptors on the oocyte plasma membrane, stimulates oocyte growth in vitro. However, this role of PI3K has not been tested using chemical inhibitors, and oocytes lacking an important mediator of its signaling activity, 3-phosphoinositidedependent protein kinase 1 (PDK1), appear to grow to full size (Zheng et al. 2010) . In the granulosa, PI3K may regulate proliferation and other aspects of differentiation. Our results indicate that oocyte growth in vitro requires PI3K signaling in one or both cell compartments. Secondly, we removed the granulosa cells that surround the oocyte. This prevents transfer of nucleotides and amino acids (and other small molecules) from the granulosa to the oocyte that normally occurs via the gap junctions that connect them and inhibits growth (Herlands & Schultz 1984) . Under both experimental conditions, however, mtDNA continued to accumulate despite the virtually complete arrest of oocyte growth. We suggest that a general growth-promoting signal may activate several downstream effector pathways, which independently regulate different aspects of the oocytegrowth program, including the increase in cell size and mtDNA replication.
A small family of regulatory proteins drive mtDNA replication in somatic cells and it is likely that these also function in oocytes. POLG, POLG2, and TFAM are of particular interest because the first two constitute the mtDNA-specific polymerase and newly replicated mtDNA is unstable unless it combines with TFAM in a nucleoprotein complex. Previous data that have suggested that TFAM might be a limiting factor in mtDNA replication in mammalian oocytes and embryos. In the pig, although Tfam declines during oocyte maturation (Spikings et al. 2007 ), both TFAM (Antelman et al. 2008 ) and mtDNA (Spikings et al. 2007) accumulate during this time. Additionally, as discussed earlier, mtDNA replication resumes in embryos near the time of implantation (Piko & Taylor 1987 , Ebert et al. 1988 , Kameyama et al. 2007 , May-Panloup et al. 2007 ; in mouse and cow, this is correlated with a sharp increase in the quantity of Tfam , May-Panloup et al. 2007 .
Our finding that Polg, Polg2, and Tfam declined following the arrest of transcription in fully grown oocytes implies that these mRNAs are unstable in mouse oocytes at this stage. This does not rule out the presence of a stable pool of protein; however, the stability of POLG and POLG2 has to our knowledge not been reported, and available antibodies are not sufficiently sensitive to detect them in mouse oocytes by immunoblotting. TFAM appears to be rapidly degraded unless it is associated with mtDNA (Ekstrand et al. 2004 , Kanki et al. 2004 , Kang et al. 2007 , which would likely prevent accumulation of a pool of free TFAM in transcriptionally active oocytes. One speculative possibility is that, as a consequence of transcriptional silencing, fully grown oocytes may possess insufficient quantities of proteins driving mtDNA replication to enable continued mtDNA accumulation (Fig. 4) . Our results show that the process of mtDNA accumulation is developmentally regulated in oocytes, but it is not yet clear whether the amount that accumulates is tightly regulated. In somatic cells, either too little or too much mtDNA can be harmful to cell health (Clay Montier et al. 2009 , Ylikallio et al. 2010 . In mammalian oocytes, comparing data obtained from different species indicates that, although the amount of mtDNA (and the number of mitochondria) seems to roughly correspond to the size of the oocyte, within a species there is considerable variability among individual oocytes (Piko & Taylor 1987 , Kameyama et al. 2007 , May-Panloup et al. 2007 , Shoubridge & Wai 2007 ).
Moreover, a recent study in the mouse indicates that oocytes containing as few as 50,000 copies of mtDNA (about 1/4-1/3 of the normal value) can give rise to healthy embryos (Wai et al. 2010) . Further work will be needed to establish whether oocytes indeed manufacture substantially more mtDNA and mitochondria than are needed for their own or embryonic development.
Materials and Methods
Animals
All experiments were performed using CD-1 female mice (Charles River Canada, St-Constant, QC, Canada) in compliance with the regulations and policies of the Canadian Council on Animal Care and were approved by the Animal Care Committee of the Royal Victoria Hospital.
Collection and culture of immature oocytes
To obtain growing and fully grown oocytes, ovaries were removed from mice between 5-and 24-day of age. For mice up to 15-day, the ovaries were transferred to HEPES-buffered minimum essential medium (MEM-HEPES, pH 7.2) supplemented with collagenase type I (1 mg/ml; Worthington Biochemical, Lakewood, NJ, USA), trypsin (0.05%; Sigma Chemicals, Windsor, ON, Canada), and DNase (0.02 mg/ml; Sigma). Ovaries were torn into fragments and pipetted up and down using 1000-ml tips and then left for 30 min at 37 8C. Using a mouth-controlled pipette, GOCs were collected and washed with fresh MEM-HEPES. When granulosa-free oocytes were required, the granulosa were removed by drawing the GOCs in and out of a narrow-bore pipette. For mice older than 18-day, the ovaries were placed in MEM-HEPES medium supplemented with sodium pyruvate (28 mg/ml; Sigma), penicillin G (63 mg/ml; Sigma), streptomycin (50 mg/ml; Sigma), and BSA (1 mg/ml; Sigma) at 37 8C, and the follicles were punctured using a 30-gauge needle. Oocytes surrounded by cumulus cells were collected. When required, the cumulus cells were removed as earlier.
To grow oocytes in vitro, GOCs isolated as described earlier from 12-day mice were transferred to Costar Transwell-COL membrane inserts (3.0 mm pore size; Ultident, Montreal, QC, Canada) in six-well cluster dishes, each well containing 4 ml MEM-NaHCO 3 supplemented as earlier and also containing cilostamide (10 mM; Sigma) to prevent spontaneous meiotic maturation and 40 ml insulin-transferrin-selenium (Sigma). Complexes were cultured for 7 days at 37 8C in a humidified atmosphere of 5% CO 2 in air (30 complexes per well). The medium (1.5 ml) was changed every second day.
To allow meiotic maturation in vitro, fully grown immature oocytes were transferred to NaHCO 3 -buffered MEM and incubated for 18 h. At the end of the incubation period, oocytes with a visible polar body were washed in MEM-HEPES and used for analysis.
Measurement of oocyte diameter and analysis of chromatin configuration
Oocytes were placed individually in a 15 ml drop of MEM-HEPES medium using a 72-well Terasaki plate (VWR Scientific, Montreal, QC, Canada) covered by mineral oil (w 5 ml) to prevent medium evaporation. The diameter of each oocyte excluding the zona pellucida was measured using the 40! objective of an inverted Zeiss LSM 510 confocal microscope. To determine chromatin configuration, oocytes were briefly stained using 1 mg/ml Hoechst 33342, then transferred to Terasaki plates as earlier, and examined using the confocal microscope.
Preparation of rabbit globin cDNA and mt-ND1 standards for quantitative PCR Rabbit mRNA (Sigma) was converted to cDNA and genomic DNA was isolated from mouse tail using standard procedures. They were subjected to PCR amplification using the primers presented in Table 1 . Amplified products were purified and recovered from agarose gels and then inserted into the pDrive cloning vector using the Qiagen PCR Cloning Kit (Qiagen) following the manufacturer's directions. Ligated products were used to transform DH5a cells and the inserted DNA was sequenced to confirm its identity. Following bacterial growth and plasmid purification, plasmid DNA was quantified using a NanoDrop spectrophotometer and the copy number was determined using the following formula: number of molecules per mlZ(amount of DNA in nanograms!(6.022!10 23 ))/ (length!(1!10 9 )!650). The plasmids containing mt-ND1 and rabbit globin were diluted to 9!10 7 copies/ml and to 1 pg/ml respectively. Aliquots for single use were prepared and stored at K20 8C.
Quantification of mtDNA
All experiments were performed using a Corbett Rotor-Gene 6000 (Montreal Biotech, Montreal, QC, Canada). Each reaction tube contained 10 ml FastStart Master SYBR Green Mix (Qiagen), 7 ml sterile ddH 2 O, 1 ml primers (10 mM), and 2 ml DNA template. Reaction conditions were 95 8C for 5 min, 40 cycles at 95 8C for 30 s, 60 8C for 30 s, and 72 8C for 30 s. The final elongation step was 7 min. A melting curve was analyzed to confirm that only one PCR product was generated.
To generate a standard curve for mt-ND1, serial dilutions (five points, tenfold dilutions) were prepared using the plasmids containing rabbit globin cDNA and mt-ND1. Each dilution was run in triplicate and three independent trials were run. Subsequently, one dilution of mt-ND1 was run in the same reaction with the samples and used to determine the absolute mtDNA copy number in individual oocytes.
To prepare the oocyte DNA, 1 pg plasmid (4.1 kb) containing the rabbit globin cDNA and 20 mg glycogen were added to each microcentrifuge tube containing a single oocyte. DNA was purified using QIAmp DNA mini kits (Qiagen). Samples were eluted twice with 50 ml sterile water and used no more than 2 days after purification.
The primers used and the expected size of the amplified products are presented in Table 1 . Primer sequences were obtained as follows: mt-ND1 (Genbank NC_005089.1), Dr L C Smith (Université de Montréal); Polg, Polg2, Tfam, and Nrf1 ; rabbit globin cDNA (Adjaye et al. 2007) ; and Actb (Arnold et al. 2008) . All were obtained from Sigma.
Drug treatments
LY294002 (Sigma) was prepared as a 20 mM stock in dimethyl sulfoxide and used at 25 mm. Each day, half of the medium containing LY294002 was replaced with a medium containing freshly diluted drug. RNA purification and cDNA synthesis
One hundred oocytes were transferred to a microcentrifuge tube in a minimal volume of medium and 9 pg rabbit globin mRNA (Sigma) was added. RNA was purified using a commercial kit (PicoPure; Arcturus Biosciences, Mountain View, CA, USA) and reverse transcribed using SuperScript II Reverse Transcription kit (Invitrogen). qPCR was performed as earlier, except that the following annealing temperatures used: Tfam and Polg2: 56 8C; Nrf1 and Polg: 57 8C. 0.4 oocyte equivalents were used for each reaction. Samples not subjected to reverse transcriptase were used to confirm the absence of genomic DNA. Relative mRNA expression was calculated using the formula 2 KðDC t sampleKDC t rabbit globinÞ .
Statistical analysis
Data were analyzed using the Student's t-test and one-way ANOVA followed by Tukey's HSD. Values are presented as meanGS.E.M. Regression analysis was performed using the function embedded in Microsoft Excel.
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